Search Results 21-30 of 22384 for neurofibromatosis
Selumetinib (Koselugo) has been approved to treat a plexiform neurofibroma in children with neurofibromatosis type 1. A plexiform neurofibroma grows on many ...
Developing Criteria for Treatment of Neurofibromatosis Type 1 Associated Optic Pathway Glioma · Overview · Participation eligibility · Participating Mayo Clinic ...
The Neurofibromatosis Clinic also has genetic counselors who can help you make decisions that are appropriate for you and your family. Counselors can help ...
The purpose of this study is to evaluate children ≥ 1 year of age and adults with neurofibromatosis type 1 (NF1) and plexiform neurofibromas treated with ...
Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple ...
The condition was previously known as neurofibromatosis type 2. People with NF2 usually have growth of tumors on the hearing and balance nerves on both ...
... Neurofibromatosis-Fact-Sheet. Accessed Feb. 21, 2024. Evans DG. NF2-related schwannomatosis (formerly neurofibromatosis type 2). https://www.uptodate.com ...
The purpose of this study is to evaluate PD-0325901 in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas ...
Neurofibromatosis and Schwannomatosis Clinic · Neurology · Neurosurgery · Oncology (Medical) · Pediatric Brain Tumor Clinic · Pediatric Hematology/Oncology ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.